Study of the SilverHawk™ /TurboHawk™ Plaque Excision Systems Used With SpiderFX to Treat Calcified Peripheral Arterial Disease (DEFINITIVE Ca++)

Clinical trial NCT00733135 · COMPLETED

Trial details

NCT number: NCT00733135
Sponsor: Medtronic Endovascular
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Peripheral Arterial Disease

Start date: 2008-10-01
Primary completion: 2010-11-01
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.